Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Clinical trial NCT02646748 · COMPLETED

Trial details

NCT number: NCT02646748
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer (CRC)Endometrial Cancer Melanoma Head and Neck Cancer Lung Cancer MMR-deficient Tumors Breast Cancer Pancreatic Cancer Renal Cell Carcinoma (RCC)Solid Tumors UC (Urothelial Cancer)

Start date: 2016-01-25
Primary completion: 2019-11-07
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.